Monster Beverage

MNST · NASDAQ

$47.04+$0.24 (+0.51%)TodayMarket closed ·
Prev close $46.80

MNST analyst rating

BuyConsensus of 16 analysts over the last 12 months. 63% rate it a buy.
  • Strong buy0
  • Buy10
  • Hold6
  • Underperform0
  • Sell0

12-month price target · 27 analysts

Average $52.29 (+11.2% upside)

Low
$36.18
Now
$47.04
High
$75.96

Upgrades and downgrades

The latest rating actions, newest first

MNST analyst upgrades, downgrades and rating actions
FirmDateActionRating
Wells FargoOct 5, 2026MaintainsOverweight
UBSAug 7, 2026MaintainsNeutral
RBC CapitalAug 7, 2026MaintainsOutperform
Piper SandlerAug 7, 2026MaintainsOverweight
Evercore ISI GroupAug 7, 2026MaintainsOutperform
BMO CapitalJul 20, 2026MaintainsMarket Perform
Deutsche BankJul 20, 2026DowngradeBuy → Hold
UBSJul 16, 2026MaintainsNeutral
StifelJul 16, 2026MaintainsBuy
CitigroupJul 14, 2026MaintainsBuy

The case for and against

Updated Oct 14, 2026

Bull case

Monster Beverage is supported by exceptional top-line momentum, with net sales up 20.2% and international sales up 34.6%, while key regions like Brazil, India, China, and APAC are still in the early innings of penetration. Its outlook is strengthened by pricing power, product mix toward zero sugar and innovation, and gross margin expansion to 55.9%, which helped offset aluminum and freight pressures despite management guiding to modest sequential cost increases. The company also has structural growth optionality from its Coca-Cola distribution relationship, broader foodservice wins, and a large addressable opportunity as it continues to outperform the global energy category at roughly 2x the growth rate.

Bear case

  • Monster Beverage is viewed negatively because operating expenses are rising faster than sales, with selling expenses at 10.6% of net sales versus 9.3% a year ago and distribution costs at 4.7% versus 3.9%, reflecting deliberate marketing intensity and inflation in freight and fuel.
  • It also faces a persistent aluminum cost headwind, as management expects a continued modest sequential increase through at least the end of 2026, while selective US Q4 pricing may not fully offset the pressure.
  • Beyond margins, the investment case is clouded by regulatory and safety headline risks, plus international distribution challenges that underpin a downside scenario assuming only ~6.9% long-run revenue CAGR and ~29% peak EBIT margins by 2035.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.